Published/Hosted by Taylor and Francis Group.
Discontinued in 2004. UroOncology aims to publish all aspects of clinical research and management of cancer of the urinary tract and male reproductive organs. The target audience uniquely encompasses a multidisciplinary group of clinicians with a special interest in treating patients with urological cancer: urologists, medical oncologists and radiation oncologists. The journal will feature prestigious reviews, original papers, selected abstracts of scientific meetings, basic science updates, a directory of urological trials (including contact points and status reports) and scientific meeting notification. Material published will be evidence-based in accordance with current thinking and following the requirements for CME, and the cross-disciplinary approach will be further promoted by the inclusion of papers on statistics, meta-analysis and ethics.
- Further information
- Category Links